Prospective monitoring of BK virus reactivation in renal transplant recipients in North India

Transplant Infectious Disease

Volumn 13, Issue 6, 2011, Pages 575-583

  Thakur, R ^a   Arora, S ^a   Nada, R ^a   Minz, M ^a   Joshi, K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

BK virus; BKV DNA load; Nephropathy; Renal transplant; SV 40 T antigen

Indexed keywords

VIRUS DNA; VIRUS LARGE T ANTIGEN;

ARTICLE; BK NEPHROPATHY; BK VIRUS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FOLLOW UP; GRAFT DYSFUNCTION; HUMAN; INCIDENCE; INDIA; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; NONHUMAN; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; SIMIAN VIRUS 40; URINALYSIS; VIREMIA; VIRUS LOAD; VIRUS PARTICLE; VIRUS REACTIVATION;

BIOPSY; BK VIRUS; DNA, VIRAL; HUMANS; INDIA; KIDNEY; KIDNEY TRANSPLANTATION; MICROSCOPY, ELECTRON; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS; URINARY TRACT INFECTIONS; VIRAL LOAD; VIREMIA;

EID: 80054967667     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00634.x     Document Type: Article

References (35)

1. Mengel M, Marwedal M, Radermacher J, et al. Incidence of polyomavirus nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 1190-1196.
2. Hirsch HH, Knowles W, Dickenman M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal transplant recipients. N Engl J Med 2002; 347: 488-496.
3. Sachdeva MU, Nada R, Jha V, Sakhuja V, Joshi K. The high incidence of BK polyomavirus infection among renal transplant recipients in India. Transplantation 2004; 77: 429-431.
4. Namba Y, Moriyama T, Kyo M, et al. Prevalence, characteristics, and outcome of BK virus nephropathy in Japanese renal transplant patients: analysis in protocol and episode biopsies. Clin Transplant 2005; 19: 97-101.
5. Hirsch HH, Steiger J. Polyomavirus BK reviews. Lancet Infect Dis 2003; 3: 611-623.
6. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361-1363.
7. Ramos E, Vincenti F, Lu WX, et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004; 77: 131-133.
8. Kitamura T, Yogo Y, Kunitake T, Suzuki K, Tajima A, Kawabe K. Effect of immunosuppression on the urinary excretion of BK and JC polyomaviruses in renal allograft recipients. Int J Urol 1994; 1: 28-32.
9. Hirsch HH. Polyomavirus BK nephropathy: a (re)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25-30.
10. Agrawal V, Gupta RK, Jain M, Prasad N, Sharma RK. Polyomavirus nephropathy and cytomegalovirus nephritis in renal allograft recipients. Indian J Pathol Microbiol 2010; 53(4): 672-675.
11. Howells DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 1999; 68: 1279-1288.
12. Tong CY, Hilton R, MacMahon EM, et al. Monitoring the progress of BK virus associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 2004; 19: 2598-2605.
13. Wali RK, Drachenberg C, Hirsch HH, et al. BK virus- associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression. Transplantation 2004; 78: 1069-1073.
14. Shah KV, Daniel R, Warszawski R. High prevalence of antibodies to BK virus, a SV-40 related papovavirus, in residents of Maryland. J Infect Dis 1973; 128: 784-787.
15. Knowles WA. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001: 527-559.
16. Maiza H, Fontaniere B, Dijoud F, Pouteil-Noble C. Graft dysfunction and polyomavirus infection in renal allograft recipients. Transplant Proc 2002; 34: 809-811.
17. Rahamimov R, Lustig S, Tovar A, et al. BK polyoma virus nephropathy in kidney transplant recipient: the role of new immunosuppressive agents. Transplant Proc 2003; 35: 604-605.
18. Kang YN, Han SM, Park KK, Jeon DS, Kim HC. BK virus infection in renal allograft recipients. Transplant Proc 2003; 35: 275-277.
19. Li RM, Mannon RB, Kleiner D, et al. BK virus and SV-40 coinfection in polyomavirus nephropathy. Transplantation 2002; 74: 1497-1504.
20. Koukoulaki M, O'Donovan M, Pursglove S, Alexopoulou D, Hadjiconstantinou V, Drakopoulos S. Prospective study of urine cytology screening for BK polyoma virus replication in renal transplant recipients. Cytopathology 2008; 19: 385-388.
21. Ramos E, Drachenberg CB, Papadimitriou JC, Wali R, Blahut S, Bartlett ST. Post transplant polyomavirus interstitial nephritis: progression of allograft dysfunction (abstract). Transplantation 2000; 69: S 386.
22. Brennan D, Agha A, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594.
23. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213-2221.
24. Koukoulaki M, Grispou E, Pistolas D, et al. Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 2009; 11(1): 1-10.
25. Singh HK, Andreoni KA, Madden V, et al. Presence of urinary haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol 2009; 20: 416-427.
26. Nickeleit V, Mihatsch J. Polyoma nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transplant Int 2006; 19: 960-973.
27. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082-2092.
28. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff Working Groups. Am J Transplant 2010; 9: 1-8.
29. Helantera I, Ortiz F, Auvinen E, et al. Polyomavirus BK and JC infections in well matched Finnish kidney transplant recipients. Transpl Int 2009; 22: 688-693.
30. Gardner SD, Mackenzie EF, Smith C, Porter AA. Prospective study of human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipient. J Clin Pathol 1984; 37: 578-586.
31. Leung AY, Chan M, Tang SC, Liang R, Kwong YL. Real time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients. J Virol Methods 2002; 103: 51-56.
32. Boudreault AA, Courtemanche C, Latulippe E, Cote I, Houde I, Deschenes L. Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement. J Clin Virol 2009; 45: 318-321.
33. Bechert CJ, Schnadig VJ, Payne DA, Dong J. Monitoring of BK viral load in renal allograft recipients by real-time PCR assays. Am J Clin Pathol 2010; 133: 242-250.
34. Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26: 671-673.
35. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-1089.